We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MDCG Highlights Need for Surveillance During Transition to IVDR
MDCG Highlights Need for Surveillance During Transition to IVDR
The EU’s surveillance system for legacy in vitro devices must remain in place during the transition to the new In Vitro Diagnostic Regulation (IVDR), according to the Medical Device Coordination Group (MDCG) of the European Medicines Agency.